INFECTIONS IN CHRONIC LYMPHOCYTIC-LEUKEMIA - RISK-FACTORS, AND IMPACT ON SURVIVAL, AND TREATMENT

被引:87
作者
MOLICA, S
机构
[1] Divisione di Ematologia, Ospedale Regionale A. Pugliese 88100, Catanzaro
关键词
INFECTIONS; CLL; SURVIVAL; TREATMENT;
D O I
10.3109/10428199409056283
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Patients with chronic lymphocytic leukemia (CLL) are at an increasing risk of infectious morbidity and mortality. Infections are generally due to bacteria and influenced by the degree of hypogammaglobulinemia; although, in more advanced stages of disease they may also be contributed by neutropenia due to bone marrow infiltration and/or cytotoxic therapy. Furthermore, defect in cell-mediated immunity appears to be a predisposing factor to infections in patients treated with newer purine analogues. Controversies surrounding the pathogenesis of infectious complications in CLL raise several questions on their management. Patients with advanced disease who receive cytotoxic therapy might qualify for antibacterial prophylaxis. Intravenous immunoglobulin (IVIG), although of scientific interest, may be of little relevance at the present time. The new growth factors should be tested in well-designed prospective studies.
引用
收藏
页码:203 / 214
页数:12
相关论文
共 117 条
[1]  
Chapel H.M., Bunch C., Mechanisms of infection in chronic lymphocytic leukemia, Semin. Hematol., 24, pp. 291-296, (1987)
[2]  
Bunch C., Management of infection in chronic lymphocytic leukaemia, Chronic Lymphocytic Leukemia. Recent Progress and Future Directions, pp. 373-381, (1987)
[3]  
Kontoyianis D.P., Anaissie E.J., Bodey G.P., Infection in chronic lymphocytic leukemia: A reappraisal, Chronic Lymphocytic Leukemia. Scientific Advances and Clinical Developments, pp. 399-417, (1993)
[4]  
Chapel H.M., Hypogammaglobulinemia and chronic lymphocytic leukemia, Chronic Lymphocytic Leukemia. Recent Progress and Future Directions, pp. 383-389, (1987)
[5]  
Rozman C., Montserrat E., Vinolas N., Serum immunoglobulins in B-CLL. Natural history and prognostic significance, Cancer, 61, pp. 279-283, (1988)
[6]  
Itala M., Helenius H., Nikoskelaien J., Remes K., Infections and serum IgG levels in patients with chronic lymphocytic leukemia, Eur. J. Haematol., 48, pp. 266-270, (1992)
[7]  
Catovsky D., Lauria F., Matutes E., Increased T-lymphocytes in B-cell chronic lymphocytic leukemia, Br. J. Haematol., 47, pp. 539-544, (1981)
[8]  
Kay N., Excessive T-cell subpopulation function in CLL: Excessive suppressor (Tγ) and defient (Tμ) activity with respect to B-cell proliferation, Blood, 57, pp. 418-420, (1981)
[9]  
Briggs P.G., Kraft N., Atkins R.C., T cells and CD45 expression in B-chronic lymphocytic leukemia, Leukemia Res., 14, pp. 155-159, (1990)
[10]  
Apostopoulos A., Symeonidis A., Zoumbos N., Prognostic significance of immune function parameters in patients with chronic lymphocytic leukaemia, Eur. J. Haematol., 44, pp. 39-44, (1990)